Northwestern Mutual Wealth Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $358K | Buy |
9,928
+2,303
| +30% | +$83K | ﹤0.01% | 1518 |
|
|
2025
Q1 | $237K | Buy |
7,625
+1,151
| +18% | +$35.8K | ﹤0.01% | 1595 |
|
|
2024
Q4 | $165K | Buy |
6,474
+2,805
| +76% | +$71.6K | ﹤0.01% | 1738 |
|
|
2024
Q3 | $104K | Buy |
3,669
+3,653
| +22,831% | +$103K | ﹤0.01% | 1882 |
|
|
2024
Q2 | $422 | Sell |
16
-44
| -73% | -$1.16K | ﹤0.01% | 3309 |
|
|
2024
Q1 | $1.82K | Buy |
+60
| New | +$1.82K | ﹤0.01% | 3072 |
|
|
2023
Q4 | – | Sell |
-71
| Closed | -$1.93K | – | 3650 |
|
|
2023
Q3 | $1.93K | Buy |
71
+12
| +20% | +$326 | ﹤0.01% | 2956 |
|
|
2023
Q2 | $1.81K | Buy |
59
+56
| +1,867% | +$1.72K | ﹤0.01% | 3002 |
|
|
2023
Q1 | $108 | Sell |
3
-188
| -98% | -$6.77K | ﹤0.01% | 3241 |
|
|
2022
Q4 | $7.55K | Buy |
+191
| New | +$7.55K | ﹤0.01% | 2599 |
|
|
2022
Q2 | – | Sell |
-2
| Closed | – | – | 3430 |
|
|
2022
Q1 | $0 | Buy |
+2
| New | – | ﹤0.01% | 3355 |
|
|
2021
Q4 | – | Sell |
-750
| Closed | -$27K | – | 3302 |
|
|
2021
Q3 | $27K | Buy |
750
+747
| +24,900% | +$26.9K | ﹤0.01% | 2111 |
|
|
2021
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 3136 |
|
|
2021
Q1 | $0 | Sell |
3
-1
| -25% | – | ﹤0.01% | 2940 |
|
|
2020
Q4 | $0 | Buy |
+4
| New | – | ﹤0.01% | 2850 |
|